These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22469316)

  • 1. Amlodipine besylate.
    Ananchenko G; Novakovic J; Lewis J
    Profiles Drug Subst Excip Relat Methodol; 2012; 37():31-77. PubMed ID: 22469316
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of oxidants to the spectrophotometric determination of amlodipine besylate in pharmaceutical formulations.
    Rahman N; Singh M; Hoda MN
    Farmaco; 2004 Nov; 59(11):913-9. PubMed ID: 15544797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amlodipine besylate-excipients interaction in solid dosage form.
    Abdoh A; Al-Omari MM; Badwan AA; Jaber AM
    Pharm Dev Technol; 2004; 9(1):15-24. PubMed ID: 15000463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of chirality on the development of robust and stable tablet formulation of (S-) amlodipine besylate.
    Hadžidedić S; Uzunović A; Sehić Jazić S; Kocova El-Arini S
    Pharm Dev Technol; 2014 Dec; 19(8):930-41. PubMed ID: 24099553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrophotometric method for the determination of amlodipine besylate with ninhydrin in drug formulations.
    Rahman N; Azmi SN
    Farmaco; 2001 Oct; 56(10):731-5. PubMed ID: 11718264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of the photochemical degradation of amlodipine.
    Fasani E; Albini A; Gemme S
    Int J Pharm; 2008 Mar; 352(1-2):197-201. PubMed ID: 18068318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photochemical stabilities of some dihydropyridine calcium-channel blockers in powdered pharmaceutical tablets.
    Kawabe Y; Nakamura H; Hino E; Suzuki S
    J Pharm Biomed Anal; 2008 Jul; 47(3):618-24. PubMed ID: 18339506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of a novel acid degradation impurity of Amlodipine Besylate using Q-TOF, NMR, IR and single crystal X-ray.
    Rapolu R; Raju ChK; Srinivas K; Awasthi A; Navalgund SG; Surendranath KV
    J Pharm Biomed Anal; 2014 Oct; 99():59-66. PubMed ID: 25072842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and optimization of spray-dried amlodipine solid dispersion for enhanced oral absorption.
    Jang DJ; Sim T; Oh E
    Drug Dev Ind Pharm; 2013 Jul; 39(7):1133-41. PubMed ID: 23009032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular dynamics, physical and thermal stability of neat amorphous amlodipine besylate and in binary mixture.
    Safna Hussan KP; Thayyil MS; Deshpande SK; Jinitha TV; Manoj K; Ngai KL
    Eur J Pharm Sci; 2018 Jul; 119():268-278. PubMed ID: 29702233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of action potential and L-type calcium channel current of Sprague-Dawley rat ventricular myocytes by different amlodipine isomers.
    Wang RX; Jiang WP
    Can J Physiol Pharmacol; 2008 Sep; 86(9):620-5. PubMed ID: 18758511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ionization, lipophilicity, and molecular modeling to investigate permeability and other biological properties of amlodipine.
    Caron G; Ermondi G; Damiano A; Novaroli L; Tsinman O; Ruell JA; Avdeef A
    Bioorg Med Chem; 2004 Dec; 12(23):6107-18. PubMed ID: 15519156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of potential impurities of amlodipine maleate.
    Sudhakar P; Nirmala M; Moses Babu J; Vyas K; Madhusudan Reddy G; Vijaya Bhaskar B; Pratap Reddy P; Mukkanti K
    J Pharm Biomed Anal; 2006 Feb; 40(3):605-13. PubMed ID: 16324814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Safety and antihypertensive efficacy of the dihydropyridine calcium antagonist Amlodipine besylate--results from an observational study in 9,672 patients].
    Keck M; Sauerbrey-Wullkopf N; Regourd E; Clemens A
    MMW Fortschr Med; 2004 Dec; 146(Suppl 3-4):115-21. PubMed ID: 15662901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of (S)-amlodipine and (R)-amlodipine on L-type calcium channel current of rat ventricular myocytes and cytosolic calcium of aortic smooth muscle cells.
    Wang RX; Jiang WP; Li XR; Lai LH
    Pharmazie; 2008 Jun; 63(6):470-4. PubMed ID: 18604992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodegradation monitoring of amlodipine by derivative spectrophotometry.
    Ragno G; Garofalo A; Vetuschi C
    J Pharm Biomed Anal; 2002 Jan; 27(1-2):19-24. PubMed ID: 11682206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose, randomized, crossover bioequivalence study of amlodipine maleate versus amlodipine besylate in healthy volunteers.
    Mignini F; Tomassoni D; Traini E; Amenta F
    Clin Exp Hypertens; 2007 Nov; 29(8):539-52. PubMed ID: 18058479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The physicochemical equivalence of eight brands of amlodipine tablets in Lagos, Nigeria.
    Olayemi SO; Akinleye MO; Awodele EO; Idris O; Oladimeji-Salami J
    West Afr J Med; 2012; 31(3):154-9. PubMed ID: 23310934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase transformations of amlodipine besylate solid forms.
    Koradia V; de Lemos AF; Allesø M; de Diego HL; Ringkjøbing-Elema M; Müllertz A; Rantanen J
    J Pharm Sci; 2011 Jul; 100(7):2896-910. PubMed ID: 21344410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.